Programmes and partnerships

In low- and middle-income countries, many people living with diabetes struggle to get the care they need. These challenges range from having medicine in stock at the pharmacy to a lack of trained doctors and nurses who can effectively diagnose and treat diabetes.

We know from experience that changing diabetes care for the better takes programmes and partnerships - no one organisation can solve the challenge alone.

For more than two decades, we've been partnering to bring solutions that help people access the diabetes care they need, no matter where they live. 


Changing Diabetes® in Children


While limited public health data exists on children with type 1 diabetes, the unbearable truth is that only few live long enough to make it into the registries in many of the world’s poorest countries.

The Changing Diabetes® in Children programme ensures care and life-saving insulin for children with type 1 diabetes in low- and middle-income countries. Working together with Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF), we have established 208 clinics in 14 countries.  Today, Changing Diabetes® in Children is providing medical care and insulin to more than 26,000 children. By 2030, we aim to expand the programme to reach 100,000.

Learn more about Changing Diabetes® in Children


Partnering to improve diabetes care in humanitarian crises

More than 70.8 million people  have been forced to flee their homes and communities due to persecution, violence and human rights violations. This is the highest number since World War II

Since 2018, we have had a partnership with the International Committee of the Red Cross , the Danish Red Cross  to tackle the growing need to improve chronic disease treatment. Our joint effort is anchored in a collective vision that all people living in humanitarian crises should have access to the healthcare they need. This partnership enables us to move quickly in times of crisis.

As a COVID-19 emergency response Novo Nordisk offers free insulin and shipment to our Red Cross partners and the humanitarian organisations we normally supply insulin to until October 2020.

Learn more about our partnership with the Red Cross


War zone

The Defeat-NCD Partnership

Access to medicine for non communicable diseases

Rapid changes in demographics and economic growth are causing a surge in the number of people impacted by chronic diseases like type 2 diabetes in many of the world’s poorest countries. 

In 2018, the Defeat-NCD Partnership was established to support countries’ efforts to both prevent and treat chronic disease. The public–private–people partnership is hosted by the United Nations Institute for Training and Research (UNITAR) and includes governments, multilateral agencies, civil society, academia, philanthropic foundations and the private sector.

Learn more about the Defeat-NCD Partnership (pdf)


Reaching the base of the pyramid


Since 2010, we have been taking an innovative approach to improve access to affordable insulin and diabetes care for the working poor in low- and middle-income countries.

For many of these patients, living with diabetes becomes a daily struggle to cover the cost of treatment and basic necessities like housing, food and transportation.

Our Base of the Pyramid programme aims to ease the cost burden related to both medicines and healthcare. Initiated in 2010, the programme is working through local health authorities and health care organisations in four African countries.

Learn more about the Base of the Pyramid programme (pdf)